Oxycodone hydrochloride and Renvela drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Oxycodone hydrochloride (oxycodone hydrochloride) and Renvela (sevelamer carbonate). Common drug interactions include chronic kidney disease among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Oxycodone hydrochloride and Renvela. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Oxycodone hydrochloride?

Oxycodone hydrochloride has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 36,817 Oxycodone hydrochloride users. Check the latest studies of Oxycodone hydrochloride.

What is Renvela?

Renvela has active ingredients of sevelamer carbonate. eHealthMe is studying from 10,923 Renvela users. Check the latest studies of Renvela.



On Aug, 02, 2026

12 people who take Oxycodone hydrochloride and Renvela together, and have interactions are studied.

Oxycodone hydrochloride and Renvela drug interactions.

What are the common drug interactions of Oxycodone Hydrochloride and Renvela, by gender? *:

female:

  1. Chronic kidney disease
  2. Death
  3. Erythema (redness of the skin)
  4. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  5. Joint swelling
  6. Lip swelling
  7. Nephrogenic anaemia (anaemia due to kidney disease)
  8. Nephropathy (damage to or disease of a kidney)
  9. Peripheral swelling
  10. Renal failure (kidney dysfunction)

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  4. Death
  5. Depression
  6. Device dislocation
  7. Dyspnoea (difficult or laboured respiration)
  8. Emotional distress
  9. Eye pain
  10. General physical health deterioration (weak health status)

What are the common drug interactions of Oxycodone Hydrochloride and Renvela, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Renal disorder (kidney disease)

30-39:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)

40-49:

n/a

50-59:

  1. Chronic kidney disease
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Depression
  5. Emotional distress
  6. Gout (uric acid crystals building up in the body)
  7. Nephrogenic anaemia (anaemia due to kidney disease)
  8. Osteoporosis (bones weak and more likely to break)
  9. Post-traumatic stress disorder
  10. Renal disorder (kidney disease)

60+:

  1. Renal failure (kidney dysfunction)
  2. Chronic kidney disease
  3. Dyspnoea (difficult or laboured respiration)
  4. Erythema (redness of the skin)
  5. Eye pain
  6. General physical health deterioration (weak health status)
  7. Hypervolaemia (abnormally increased volume of blood)
  8. Joint swelling
  9. Lip swelling
  10. Muscle twitching

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 33.33%
  2. High Blood Cholesterol: 3 people, 25.00%
  3. Haemochromatosis (body to absorb more iron than usual from food): 2 people, 16.67%
  4. Blood Pressure Abnormal: 2 people, 16.67%
  5. Diabetes: 2 people, 16.67%
  6. Gout (uric acid crystals building up in the body): 2 people, 16.67%
  7. High Blood Pressure: 2 people, 16.67%
  8. Asthma: 1 person, 8.33%
  9. Bacterial Infection: 1 person, 8.33%
  10. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Oxycodone hydrochloride and Renvela?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Oxycodone hydrochloride and Renvela:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Oxycodone hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Renvela:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oxycodone hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Renvela and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on oxycodone hydrochloride and sevelamer carbonate (the active ingredients of Oxycodone hydrochloride and Renvela, respectively), and Oxycodone hydrochloride and Renvela (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: